Nuacht

Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street ...
The Pharma Letter39 nóiméad
The week in pharma: action, reaction and insight – week to June 27
US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...
Stifel Resumed Coverage on V2X, Inc (VVX), Kept the PT Unchanged
V2X, Inc. (NYSE:VVX) is one of the 13 Best Aerospace and Defense Stocks to Invest in Now. On June 23, Stifel resumed coverage ...
Could YOU make a pile of cash investing in the never-ending craze for Mounjaro and Ozempic?
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
Could YOU make a pile of cash from the never-ending craze for Mounjaro and Ozempic? ANNE ASHWORTH reveals everything you need to know
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...